Neogenomics Inc
NASDAQ:NEO
Neogenomics Inc
Operating Expenses
Neogenomics Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Neogenomics Inc
NASDAQ:NEO
|
Operating Expenses
-$349.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-28%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Expenses
-$9.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
|
Danaher Corp
NYSE:DHR
|
Operating Expenses
-$16.1B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Expenses
-$1.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Expenses
-$2.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Expenses
-$3.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-14%
|
See Also
What is Neogenomics Inc's Operating Expenses?
Operating Expenses
-349.7m
USD
Based on the financial report for Mar 31, 2024, Neogenomics Inc's Operating Expenses amounts to -349.7m USD.
What is Neogenomics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-28%
Over the last year, the Operating Expenses growth was -5%. The average annual Operating Expenses growth rates for Neogenomics Inc have been -20% over the past three years , -21% over the past five years , and -28% over the past ten years .